Today
NeuroPhysics is fully focused on the application of
its innovative imaging technologies to reduce the
cost of drug discovery and development.
Our
mission is to provide and promote the use of
quantitative imaging modalities by pharmaceutical
companies, contract research organizations, (CROs)
and university research groups in order to expedite
the drug discovery and development process.
In
pursuit of its mission, NeuroPhysics
is:
•
Actively pursuing
strategic alliances with CRO, universities and
pharmaceutical companies to promote the use of best
technologies as early as possible in the drug
discovery process.
• Actively pursuing
grants from medical foundations to research
innovative modeling and analytical methods for
accurate drug effect quantification.
• Developing a
combined MRI and scanning focal-point microscope
imaging system for precise location and quantitative
analysis of drug effect.
Within
the next three years, NeuroPhysics intends
to:
• Replace the
obsolete equipment currently used in drug development
industry and greatly expand the use of its SPECT
scanning microscope for molecular imaging.
• Introduce a small
animal MRI and integrate it with its SPECT scanning
microscope.
• Be a one-stop
supplier to CROs for functional and anatomical
imaging of small animals.